MOTS
Price:
$0.035
Market Cap:
$223.61K
Motus GI Holdings, Inc. operates as a medical technology company in the United States. It develops Pure-Vu system, a medical device to facilitate the cleansing of a poorly prepared gastrointestinal tract during the colonoscopy and facilitates upper gastrointestinal endoscopy procedures. The company was formerly known as Eight-Ten Merger Corp. and changed its name to Motus GI Holdings, Inc. in November 2016. The company was founded in 2008 and is based in Fort Lauderdale, Florida.[Read more]
Industry
Healthcare
IPO Date
2018-02-14
Stock Exchange
PNK
Ticker
MOTS
According to Motus GI Holdings, Inc.’s latest financial reports and current stock price. The company's current ROE is -1466.82%. This represents a change of -1963.18% compared to the average of 78.73% of the last 4 quarters.
The mean historical ROE of Motus GI Holdings, Inc. over the last ten years is -206.39%. The current -1466.82% ROE has changed 610.69% with respect to the historical average. Over the past ten years (40 quarters), MOTS's ROE was at its highest in in the March 2023 quarter at 406.73%. The ROE was at its lowest in in the September 2022 quarter at -685.43%.
Average
-206.39%
Median
-173.60%
Minimum
-607.69%
Maximum
160.92%
Discovering the peaks and valleys of Motus GI Holdings, Inc. ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 210.32%
Maximum Annual ROE = 160.92%
Minimum Annual Increase = -149.71%
Minimum Annual ROE = -607.69%
Year | ROE | Change |
---|---|---|
2023 | -478.86% | -21.20% |
2022 | -607.69% | 210.32% |
2021 | -195.83% | 12.81% |
2020 | -173.60% | 40.82% |
2019 | -123.28% | 2.56% |
2018 | -120.20% | -49.71% |
2017 | -239.00% | 198.76% |
2016 | -80.00% | -149.71% |
The current ROE of Motus GI Holdings, Inc. (MOTS) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages
3-year avg
-427.46%
5-year avg
-315.85%
10-year avg
-206.39%
Motus GI Holdings, Inc.’s ROE is greater than ENDRA Life Sciences Inc. (-162.48%), greater than electroCore, Inc. (-165.17%), greater than Aileron Therapeutics, Inc. (-47.94%), greater than Check-Cap Ltd. (-58.02%), greater than VYNE Therapeutics Inc. (-43.96%),
Company | ROE | Market cap |
---|---|---|
-162.48% | $417.25K | |
-165.17% | $38.29M | |
-47.94% | $60.66M | |
-58.02% | $10.88M | |
-43.96% | $28.02M |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Motus GI Holdings, Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Motus GI Holdings, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the ROE?
How can you use the ROE?
What is Motus GI Holdings, Inc.'s ROE?
How is the ROE calculated for Motus GI Holdings, Inc. (MOTS)?
What is the highest ROE for Motus GI Holdings, Inc. (MOTS)?
What is the 3-year average ROE for Motus GI Holdings, Inc. (MOTS)?
What is the 5-year average ROE for Motus GI Holdings, Inc. (MOTS)?
How does the current ROE for Motus GI Holdings, Inc. (MOTS) compare to its historical average?